DK1697005T3 - Kombination af flupirtin og tramadol - Google Patents

Kombination af flupirtin og tramadol

Info

Publication number
DK1697005T3
DK1697005T3 DK04803682.6T DK04803682T DK1697005T3 DK 1697005 T3 DK1697005 T3 DK 1697005T3 DK 04803682 T DK04803682 T DK 04803682T DK 1697005 T3 DK1697005 T3 DK 1697005T3
Authority
DK
Denmark
Prior art keywords
flupirtine
tramadol
combination
treament
pain
Prior art date
Application number
DK04803682.6T
Other languages
English (en)
Inventor
Joachim Maus
Peter Juergen Cnota
Istvan Szelenyi
Original Assignee
Meda Pharma Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meda Pharma Gmbh & Co Kg filed Critical Meda Pharma Gmbh & Co Kg
Application granted granted Critical
Publication of DK1697005T3 publication Critical patent/DK1697005T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Artificial Filaments (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK04803682.6T 2003-12-17 2004-12-09 Kombination af flupirtin og tramadol DK1697005T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52976103P 2003-12-17 2003-12-17
PCT/EP2004/014025 WO2005058420A1 (en) 2003-12-17 2004-12-09 Combination of flupirtine and tramadol

Publications (1)

Publication Number Publication Date
DK1697005T3 true DK1697005T3 (da) 2011-12-12

Family

ID=34700037

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04803682.6T DK1697005T3 (da) 2003-12-17 2004-12-09 Kombination af flupirtin og tramadol

Country Status (18)

Country Link
US (1) US7553858B2 (da)
EP (1) EP1697005B1 (da)
JP (1) JP4933265B2 (da)
CN (1) CN1889996A (da)
AT (1) ATE525112T1 (da)
AU (1) AU2004298333B2 (da)
CA (1) CA2546302C (da)
DK (1) DK1697005T3 (da)
ES (1) ES2373957T3 (da)
HR (1) HRP20110914T1 (da)
MX (1) MXPA06006999A (da)
NO (1) NO335734B1 (da)
NZ (1) NZ547256A (da)
PL (1) PL1697005T3 (da)
PT (1) PT1697005E (da)
RU (1) RU2463042C2 (da)
SI (1) SI1697005T1 (da)
WO (1) WO2005058420A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006024018A2 (en) * 2004-08-24 2006-03-02 Neuromolecular Pharmaceuticals, Inc. Compositions for treating nociceptive pain
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
EP1874282B1 (en) 2005-04-06 2010-09-15 Adamas Pharmaceuticals, Inc. Methods and compositions for treatment of cns disorders
JP2010525069A (ja) * 2007-04-27 2010-07-22 パラテック ファーマシューティカルズ インコーポレイテッド アミノアルキルテトラサイクリン化合物の合成方法および精製方法
CN102333532A (zh) * 2009-01-30 2012-01-25 瑞乐威尔澳大利亚私人有限公司 药物抗滥用,方法及组合物
DE102010063612A1 (de) 2010-12-20 2012-06-21 Awd.Pharma Gmbh & Co. Kg Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamidsäureethylester und 2-[2-[(2,6-Dichlorphenyl)-amino]-phenyl]-essigsäure
DE102010063609A1 (de) 2010-12-20 2012-06-21 Awd.Pharma Gmbh & Co. Kg Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3yl)-carbamidsäureethylester und einer Arylpropionsäure
CN104302277A (zh) * 2012-03-02 2015-01-21 Meda制药有限及两合公司 含有氟吡汀的药物制剂
US9693949B1 (en) 2015-12-22 2017-07-04 Revogenex Ireland Ltd Intravenous administration of tramadol
US9980900B2 (en) 2015-12-22 2018-05-29 Revogenex Ireland Ltd Intravenous administration of tramadol
RU2678976C1 (ru) * 2018-03-21 2019-02-05 федеральное государственное бюджетное образовательное учреждение высшего образования "Тверской государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ профилактики длительного болевого синдрома в отдаленном послеоперационном периоде у пациентов с дисплазией соединительной ткани

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0532627A (ja) * 1991-07-29 1993-02-09 Asta Medica Ag 筋肉痙攣により帰因するか又は筋肉痙攣の結果である疾病及び症候群を治療するための医薬品及びその製法
DE4236752A1 (de) * 1992-10-30 1994-05-05 Asta Medica Ag Kombinationspräparat aus Flupirtin und Morphin zur Behandlung von Schmerzen und zur Vermeidung der Morphin-Abhängigkeit
DE19807535A1 (de) * 1998-02-21 1999-08-26 Asta Medica Ag Pharmazeutische Kombinationen mit Tramadol
AU7271700A (en) * 1999-08-03 2001-02-19 Awd.Pharma Gmbh & Co. Kg Use of flupirtine for alleviating pain caused by degenerative joint diseases in dogs and cats
RU2218189C1 (ru) * 2002-05-28 2003-12-10 Нижегородская государственная медицинская академия Способ лечения мигрени в межприступном периоде заболевания

Also Published As

Publication number Publication date
EP1697005A1 (en) 2006-09-06
JP4933265B2 (ja) 2012-05-16
RU2006125520A (ru) 2008-01-27
RU2463042C2 (ru) 2012-10-10
US20050137235A1 (en) 2005-06-23
HRP20110914T1 (hr) 2011-12-31
WO2005058420A1 (en) 2005-06-30
US7553858B2 (en) 2009-06-30
CA2546302C (en) 2012-05-22
NO20063308L (no) 2006-09-12
NZ547256A (en) 2009-04-30
AU2004298333A1 (en) 2005-06-30
AU2004298333B2 (en) 2009-12-17
ATE525112T1 (de) 2011-10-15
PL1697005T3 (pl) 2012-02-29
PT1697005E (pt) 2011-12-29
EP1697005B1 (en) 2011-09-21
ES2373957T3 (es) 2012-02-10
NO335734B1 (no) 2015-02-02
CA2546302A1 (en) 2005-06-30
JP2007514672A (ja) 2007-06-07
MXPA06006999A (es) 2006-12-14
CN1889996A (zh) 2007-01-03
SI1697005T1 (sl) 2012-01-31

Similar Documents

Publication Publication Date Title
NO20063308L (no) Kombinasjon av flupirtin og tramadol
DK1404331T3 (da) Sustained release-formuleringer af oxymorphon
IS6957A (is) Tatrat sölt af 5,8,14,-tríasatetrasýkló[10.3.1.02,11.04,9]-hexadeka-2(11),3,5,7,9,-pentaen og lyfjafræðilegar samsetningar af þeim
CY1105082T1 (el) Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας
NO20035298D0 (no) CDK-inhiberende pyrimider, deres fremstilling og deres anvendelse som legemidler
DK1537096T3 (da) Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf
DK1673104T3 (da) Fremføring af terapeutiske forbindelser til hjernen og andre væv
DK1564210T3 (da) 4-Oxoquinolinforbindelser og anvendelse deraf som HIV-integraseinhibitorer
DK1513873T3 (da) Terapeutiske epitoper og anvendelser deraf
NO20051983D0 (no) 3-fenyl-substituert pyridoindolon, fremstilling derav og terapeutisk anvendelse derav.
NO20044322L (no) Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament
DK1513836T3 (da) Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
NO20050689L (no) Terapeutisk anvendelse
IS7825A (is) Meðferðarfræðileg meðhöndlun
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
NO20024838D0 (no) Salter av bicykliske, N-acylerte imidazo-3-aminer og imidazo- 5-aminer
NO20033123L (no) Terapeutisk hinne dannende sammensetning og behandlingsplan derav
DK1404304T3 (da) Tablet omfattende cetirizin og pseudoephedrin
DK1478366T3 (da) Farmaceutiske kombinationer af meloxicam, codeinphosphat og paracetamol
IS2487B (is) Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á
DE60326734D1 (de) Ligations-behandlungsgerät
DE60305053D1 (de) Pyrimidinderivate als selektive cox-2-inhibitoren
IS2331B (is) 2-arýlimínó-2,3-díhýdróþíasólafleiður, aðferðir til að framleiða þær og meðferðarfræðileg notkun þeirra
ATE343576T1 (de) 7-azaindolderivate als cox2-inhibitoren
DK1455770T3 (da) Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser